Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on April 1, 2025
Liquidity.io unveils LQDTY, a Layer 1 Blockchain with Biometrics by Telos Corporation
EIN Presswire
·
April 1, 2025
LQDTY introduces a next-gen decentralized ecosystem with frictionless transactions, biometric security, and advanced compliance solutions. WHITEFISH, MT, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- LQDTY, an innovative Layer 1 blockchain platform …
MindWaveDAO gears up to List NILA Token on LBank Exchange on April 14, 2025, 11.00 AM UTC.
EIN Presswire
·
April 1, 2025
MindWaveDAO's team is prepping for the LBank Exchange after achieving the Stage 1 Fundraising target. Currently, in Stage 2 to achieve envisioned milestones. DUBAI, UNITED ARAB EMIRATES, April 1, 2025 /EINPresswire.com/ -- MindWaveDAO, a next-generation …
TOKEN2049 Dubai: 30 Days to Go – On Track to Sell Out Amid Record-Breaking Demand
EIN Presswire
·
April 1, 2025
TOKEN2049 Dubai will take place at Madinat Jumeirah from 30 April-1 May, bringing together 15,000 attendees from across the globe for an unparalleled experience DUBAI, UNITED ARAB EMIRATES, April 1, 2025 /EINPresswire.com/ -- This time next month, …
UltraSight Showcases New Data at ACC 2025 Highlighting the Accuracy and Accessibility of AI-Guided Cardiac Imaging
EIN Presswire
·
April 1, 2025
Research shows how UltraSight’s Real-Time Guidance software empowers wider access to diagnostic-quality cardiac imaging—regardless of operator experience BOSTON, MA, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- UltraSight™, a digital health leader …
Quorum Software Launches Global Partner Advantage Program
EIN Presswire
·
April 1, 2025
Empowering Collaboration and Accelerating Partner Success HOUSTON, TX, UNITED STATES, April 1, 2025 /EINPresswire.com/ -- Quorum Software, a global leader in energy software, today announced the launch of the Quorum Partner Advantage Program, a …
COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order
GlobeNewswire
·
April 1, 2025
TORONTO, ONTARIO, April 01, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a life science company which develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical and …
NowVertical Reports Record 2024 Financial Results
GlobeNewswire
·
April 1, 2025
Company Hosting Investor Webinar on April 2, 2025, at 10:00 AM EST Q4 2024 revenue was $10.9 million, up 94% Y/Y excluding recent divestitures On a reported basis, Q4 2024 revenue increased 8% Y/Y Q4 2024 Net Income was $0.6 million, up 115% Y/Y excluding …
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 1, 2025
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
Ero Copper to Release First Quarter 2025 Operating and Financial Results on May 5, 2025
GlobeNewswire
·
April 1, 2025
VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) (the “Company”) will publish its first quarter 2025 operating and financial results on Monday, May 5, 2025, after market close. The Company will host a …
Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis
GlobeNewswire
·
April 1, 2025
Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort Topline results from NATiV3 projected in the second half of 2026 and, if positive, expected to be the basis for submission for regulatory …
Inventiva annonce la fin du recrutement de l’étude clinique de Phase 3 NATiV3 évaluant lanifibranor chez les patients atteints de MASH et de fibrose avancée
GlobeNewswire
·
April 1, 2025
Objectifs de recrutement dépassés avec 1.009 patients randomisés dans la cohorte principale et 411 dans la cohorte exploratoire Principaux résultats de NATiV3 attendus au deuxième semestre 2026 et, si positifs, ils supporteront les demandes règlementaires …
Helios Fairfax Partners to Host Investor Presentation on Wednesday, April 9, 2025, at 2:30 pm ET and Annual and Special Meeting of Shareholders on Wednesday, May 14, 2025, at 11:00 am ET
GlobeNewswire
·
April 1, 2025
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) (“HFP”) today announced it will host an Investor Presentation on …
Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire
·
April 1, 2025
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that the Compensation and Human …
HCW Biologics Announces 1-for-40 Reverse Stock Split
GlobeNewswire
·
April 1, 2025
MIRAMAR, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by …
Castle Biosciences to Present New Data at EADO Supporting the Clinical Value of the DecisionDx®-Melanoma Test in Guiding Risk-Aligned Management of Patients with Melanoma
GlobeNewswire
·
April 1, 2025
Two posters will share data on the significant risk stratification provided by DecisionDx-Melanoma in a real-world cohort of patients with stage IIB-IIC cutaneous melanoma (CM) to help guide adjuvant therapy, and the role of the test in prompting use of …
Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 1, 2025
FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that, in …
Polyrizon Ltd. Announces Closing of $17.0 Million Private Placement
GlobeNewswire
·
April 1, 2025
RAANANA, ISRAEL, April 01, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a biotech company specializing in innovative intranasal hydrogels, today announced the closing of its previously announce private placement of approximately …
nCino Reports Fourth Quarter and Fiscal Year 2025 Financial Results
GlobeNewswire
·
April 1, 2025
Q4 Total Revenues of $141.4M, up 14% year-over-year Fiscal Year 2025 Total Revenues of $540.7M, up 13% year-over-year Q4 Subscription Revenues of $125.0M, up 16% year-over-year Fiscal Year 2025 Subscription Revenues of $469.2M, up 15% year-over-year …
Jamf completes acquisition of Identity Automation, expanding its platform to include dynamic identity management for specific industries
GlobeNewswire
·
April 1, 2025
MINNEAPOLIS, April 01, 2025 (GLOBE NEWSWIRE) -- Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, today announced it has completed the acquisition of Identity Automation, a dynamic identity and access management (IAM) platform for …
nCino Announces Stock Repurchase Program
GlobeNewswire
·
April 1, 2025
WILMINGTON, N.C., April 01, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced that its Board of Directors has authorized a Stock Repurchase Program under which the …